Table 1.

Clinical Data

	Baseline	Follow-up	p
Age	44 (24.5–56)
Sex (% female)	78.8
BMI	25.3 (23.4–26.5)	25.0 (23.4–27.2)	0.25
TSH at screening (mIU/L)	17.0 (10.8–53.0)
fT4 at screening (pmol/L)	10.8 (5.7–14.9)
TSH baseline (mIU/L)	10.88 (6.8–40.1)	1.73 (0.3–3.9)	<0.0001
fT4 (pmol/L)	12.2 (9.7–17.2)	19 (17.0–21.2)	<0.0001
fT3 (pmol/L)	4.1 (3.3–4.6)	4.4 (4.0–5.0)	0.068
Body muscle mass %	53.5 (48–59.8)	53 (48.5–59)	0.32
Body fat mass %	25.5 (15.3–32.3)	23 (15–28.5)	0.38
Estimated BMR (kcal/day)	1365 (1300–1527)	1392 (1297–1585)	0.46
Glucose (mmol/L)	4.8 (4.5–4.9)	4.8 (4.4–5.1)	0.94
Triglycerides (mmol/L)	1.0 (0.7–1.23)	1.0 (0.8–1.4)	0.70
LDL cholesterol (mmol/L)	3.1 (2.2–3.4)	2.6 (2.1–3.3)	0.063
Total cholesterol (mmol/L)	4.9 (4.4–5.6)	4.7 (4.0–5.3)	0.023
HDL cholesterol (mmol/L)	1.8 (1.5–2.1)	1.6 (1.3–1.8)	0.0002

Data are given as the median and interquartile range (n = 33).

BMI, body mass index; TSH, thyrotropin; fT4, free thyroxine; fT3, free triiodothyronine; BMR, basal metabolic rate; LDL, low-density lipoprotein; HDL, high-density lipoprotein.